McRae Capital Management’s Novo Nordisk NVO Stock Holding History

McRae Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-9,400	Closed	-$240K	–	95
2019 Q2	$240K	Hold	9,400	–	–	0.1%	82
2019 Q1	$246K	Sell	9,400 -4,900	-34%	-$120K	0.1%	81
2018 Q4	$329K	Sell	14,300 -8,000	-36%	-$178K	0.17%	68
2018 Q3	$526K	Sell	22,300 -500	-2%	-$12.2K	0.22%	49
2018 Q2	$526K	Hold	22,800	–	–	0.22%	56
2018 Q1	$561K	Sell	22,800 -2,000	-8%	-$52.5K	0.25%	46
2017 Q4	$666K	Sell	24,800 -9,430	-28%	-$240K	0.28%	45
2017 Q3	$824K	Hold	34,230	–	–	0.35%	41
2017 Q2	$734K	Buy	34,230 +1,000	+3%	+$20.2K	0.3%	42
2017 Q1	$570K	Sell	33,230 -3,500	-10%	-$60.9K	0.23%	46
2016 Q4	$659K	Buy	36,730 +1,040	+3%	+$18.9K	0.29%	43
2016 Q3	$742K	Hold	35,690	–	–	0.34%	40
2016 Q2	$960K	Buy	35,690 +5,600	+19%	+$154K	0.44%	37
2016 Q1	$815K	Buy	+30,090	New	+$806K	0.36%	38

Other funds holding NVO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

McRae Capital Management's NVO Position: Q3 2019 in Review

McRae Capital Management sold out of Novo Nordisk (NVO) in Q3 2019, closing a stake of 9,400 shares — an estimated $240K sold.

McRae Capital Management first reported a position in NVO in Q1 2016 and held it in 14 quarters. The position peaked at $960K in Q2 2016. 564 funds tracked by Wall St. Rank hold NVO as of Q3 2019.

McRae Capital Management reported no remaining Novo Nordisk position as of Q3 2019 after selling out during the quarter.
McRae Capital Management sold 9,400 Novo Nordisk shares in Q3 2019, an estimated $240K.
McRae Capital Management first reported a position in Novo Nordisk in Q1 2016 and held it in 14 quarters.
McRae Capital Management's Novo Nordisk position peaked at $960K in Q2 2016.
564 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2019.

Based on McRae Capital Management's 13F filing for Q3 2019, filed 21 Oct 2019.